PRESS RELEASE published on 12/11/2025 at 07:00, 4 months ago Informations privilégiées / Autres communiqués Innate Pharma publie son calendrier financier pour 2026, incluant la publication des résultats annuels et semestriels, ainsi que des chiffres d'affaires trimestriels Chiffre D'affaires Calendrier Financier Résultats Annuels Innate Pharma Immunothérapies
PRESS RELEASE published on 12/11/2025 at 07:00, 4 months ago Inside Information / Other news releases Innate Pharma releases its 2026 financial calendar, including key dates for financial statements and shareholder meetings. Find details on the company's website Euronext Financial Calendar Nasdaq Innate Pharma 2026
BRIEF published on 11/28/2025 at 07:05, 4 months 13 days ago Nouveau nombre d'actions et droits de vote d'Innate Pharma Euronext Paris Capital Social Nasdaq Innate Pharma Actions Et Droits
BRIEF published on 11/28/2025 at 07:05, 4 months 13 days ago New number of shares and voting rights of Innate Pharma Euronext Paris Share Capital Nasdaq Innate Pharma Shares And Rights
PRESS RELEASE published on 11/28/2025 at 07:00, 4 months 13 days ago Informations privilégiées / Autres communiqués Innate Pharma communique le nouveau nombre d'actions et de droits de vote au 27 novembre 2025 selon la réglementation en vigueur avec 92 196 523 actions ordinaires et 92 962 943 droits de vote théoriques Droits De Vote Actions AMF Innate Pharma Biotechnologies
BRIEF published on 11/17/2025 at 07:05, 4 months 24 days ago Innate Pharma to Present at Jefferies Global Healthcare Conference Biotechnology Immunotherapy Innate Pharma Jefferies Conference Antibody Therapeutics
BRIEF published on 11/17/2025 at 07:05, 4 months 24 days ago Innate Pharma présentera ses travaux lors de la conférence mondiale sur les soins de santé de Jefferies. Biotechnologie Immunothérapie Innate Pharma Conférence Jefferies Thérapeutiques Par Anticorps
PRESS RELEASE published on 11/17/2025 at 07:00, 4 months 24 days ago Informations privilégiées / Autres communiqués Innate Pharma présentera lors de la Jefferies Global Healthcare Conference à Londres le 17 novembre 2025. La société développe des traitements d'immunothérapies contre le cancer Société Cancer Innate Pharma Jefferies Global Healthcare Conference Immunothérapies
PRESS RELEASE published on 11/17/2025 at 07:00, 4 months 24 days ago Inside Information / Other news releases Innate Pharma to present at Jefferies Global Healthcare Conference on November 17, 2025. A global biotechnology company focusing on cancer immunotherapies Biotechnology Immunotherapy Cancer Innate Pharma Jefferies Global Healthcare Conference
BRIEF published on 10/14/2025 at 07:05, 5 months 28 days ago Innate Pharma met en avant lacutamab lors d'un événement analystes et investisseurs Investisseurs Essai Clinique Innate Pharma Lacutamab Syndrome De Sézary
Published on 04/11/2026 at 02:00, 19 hours 23 minutes ago Lobe Sciences Ltd. Announces Non-Brokered Private Placement
Published on 04/11/2026 at 01:40, 19 hours 43 minutes ago Arctic Fox Announces Closing of Final Tranche Of Non-Brokered Private Placement
Published on 04/11/2026 at 00:30, 20 hours 53 minutes ago Trans Canada Gold Corp. Announces Proposed Warrant Extension
Published on 04/10/2026 at 23:30, 21 hours 53 minutes ago Clean Air Metals Announces Management Changes
Published on 04/10/2026 at 23:15, 22 hours 8 minutes ago Gemdale Announces Change of Corporate Secretary
Published on 04/11/2026 at 16:45, 4 hours 38 minutes ago CGTN: One family: Xi Jinping stresses keeping future of cross-Strait ties in Chinese hands
Published on 04/11/2026 at 16:40, 4 hours 43 minutes ago VARON Delivers Advanced Portable Oxygen Concentrator to Meet Rising Demand in Europe
Published on 04/11/2026 at 16:30, 4 hours 53 minutes ago VARON Oxygen Concentrators Meet Rising Demand for Modern Oxygen Therapy in Germany
Published on 04/10/2026 at 19:00, 1 day 2 hours ago EPIC Suisse AG – Annual General Meeting 2026 approves all proposals by the Board of Directors
Published on 04/11/2026 at 16:29, 4 hours 54 minutes ago Décès de Madame Jacqueline Himsworth, Présidente du Conseil d’administration de Manitou Group
Published on 04/11/2026 at 16:29, 4 hours 54 minutes ago Passing of Madame Jacqueline Himsworth, Chairman of the Board of Directors of Manitou Group
Published on 04/10/2026 at 18:26, 1 day 2 hours ago EURAZEO ANNOUNCES THE SUCCESS OF ITS INAUGURAL 500 MILLION EURO BOND ISSUE
